The Use of Trifluoperazine in Transfusion Dependent DBA

Stopped Supporter terminated study due to slow subject accrual secondary to COVID pandemic limiting travel to research site.

Conditions

• Diamond Blackfan Anemia
• Pure Red Cell Aplasia

Interventions

• DRUG: Trifluoperazine

Sponsor

Adrianna Vlachos, MD